XML 42 R28.htm IDEA: XBRL DOCUMENT v3.25.1
STOCKHOLDERS DEFICIENCY (Tables)
9 Months Ended
Mar. 31, 2025
STOCKHOLDERS DEFICIENCY  
Equity Distribution Agreement

 

 

Nine Months Ended 

March 31, 2024

 

 

Cumulative from

inception

 

 

 

Shares

 

 

Proceeds

 

 

Shares

 

 

Proceeds

 

Gross proceeds

 

 

217,027

 

 

$547,803

 

 

 

721,061

 

 

$1,744,542

 

Fees

 

 

-

 

 

 

(16,434)

 

 

-

 

 

 

(52,336)

Expenses

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(126,800)

Net proceeds

 

 

217,027

 

 

$531,369

 

 

 

721,061

 

 

$1,565,406

 

Outstanding Stock Purchase Warrants

 

 

Shares of Common

 

 

Exercise Price per

 

 

Latest Expiration

 

Description

 

Stock

 

 

Share

 

 

Date

 

May 2022 Warrants

 

 

66,666

 

 

$12.50

 

 

May 11, 2026

 

October 2022 Placement Agent Warrants

 

 

90,909

 

 

$6.88

 

 

October 31, 2027

 

October 2023 Placement Agent Warrants

 

 

117,925

 

 

$2.65

 

 

October 20, 2028

 

January 2024 Private Warrants

 

 

1,831,503

 

 

$5.46

 

 

February 1, 2028

 

January 2024 Placement Agent Warrants

 

 

91,575

 

 

$6.83

 

 

February 1, 2028

 

June 2024 Series B Warrants

 

 

1,885,632

 

 

$1.88

 

 

June24,2029*

 

December 2024 Series C Warrants

 

 

3,907,679

 

 

$0.88

 

 

December 17, 2029

 

December 2024 Series D Warrants

 

 

1,953,839

 

 

$0.88

 

 

**

 

February 2025 Series E Warrants

 

 

4,688,000

 

 

$1.00

 

 

August 12, 2030

 

 

 

 

 

 

 

 

 

 

 

 

 

* 1,624,201 shares expire on the five year anniversary following stockholder approval of the warrant issuance and the balance expire on June 24, 2029.

 

** 1,953,839 shares expire on the five year anniversary following stockholder approval of the warrant issuance.

 

 

 

 
Option activity

 

 

Number of Shares

 

 

Weighted Average

Exercise Price

 

 

Weighted Average Remaining

Term in Years

 

 

Aggregate Intrinsic

Value

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Outstanding - June 30, 2024

 

 

2,263,440

 

 

$6.11

 

 

 

8.2

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Granted

 

 

-

 

 

 

-

 

 

 

 

 

 

 

 

Forfeited

 

 

-

 

 

 

-

 

 

 

 

 

 

 

 

Exercised

 

 

-

 

 

 

-

 

 

 

 

 

 

 

 

Expired

 

 

(14,338)

 

 

4.50

 

 

 

 

 

 

 

 

Outstanding - March 31, 2025

 

 

2,249,102

 

 

$6.12

 

 

 

7.5

 

 

$-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Exercisable at March 31, 2025

 

 

937,894

 

 

$10.77

 

 

 

5.9

 

 

$-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Expected to vest at March 31, 2025

 

 

1,311,208

 

 

$2.80

 

 

 

8.6

 

 

$-

 

Restricted Stock Units

Outstanding at June 30, 2024

 

 

1,374,980

 

Granted

 

 

-

 

Forfeited

 

 

-

 

Vested

 

 

(232,941)

Expirations

 

 

(2,726)

Outstanding at March 31, 2025

 

 

1,139,313